Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers

PURPOSE: Midostaurin (PKC412) is a multitargeted tyrosine kinase inhibitor of FMS-like tyrosine kinase 3 receptor (FLT3), c-KIT, and other receptors. Midostaurin is active in patients with acute myeloid leukemia and systemic mastocytosis. Although no substantive risk for cardiac abnormalities has be...

Descripción completa

Detalles Bibliográficos
Autores principales: del Corral, Adam, Dutreix, Catherine, Huntsman-Labed, Alice, Lorenzo, Sebastien, Morganroth, Joel, Harrell, Robert, Wang, Yanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337405/
https://www.ncbi.nlm.nih.gov/pubmed/22294470
http://dx.doi.org/10.1007/s00280-012-1825-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337405/
https://www.ncbi.nlm.nih.gov/pubmed/22294470
http://dx.doi.org/10.1007/s00280-012-1825-y

Ejemplares similares